A rising star at Horizon Therapeutics and in the pharmaceutical industry, Laura Rodgers focuses on finding ways to provide greater relevance and value for patients, deliver greater impact on her organization’s business, and elevate smarter marketing practice to the industry as a whole.
As a member of the Krystexxa brand team, Rodgers leveraged pharmaceutical competitive analysis, market research, and analytics to design and execute winning strategies for an orphan biologic treatment, while driving profitability and market share.
With the drug’s relaunch as the first biologic for the treatment of chronic gout refractory to conventional therapies, she helped drive more than 50% growth two years in a row. She led efforts to launch Krystexxa to nephrologists with new tools to support educating specialists, resulting in 57 new accounts and 75-plus patients on therapy within the first six months.
Rodgers also played an integral role in the development of the aggNET interactive visual aid, which has seen phenomenal results, with sales representatives completing the experience 60% of the time they detail it.